In neurological contexts, different mutations (including microdeletions, microduplications, methylation changes and single-nucleotide variants) that result in a DLG1 deficiency have been shown in schizophrenia, autism, Parkinson’s disease, epilepsy and cerebral palsy (Marziali et al. 2019). The gene discussed is DLG1; the disease is Parkinson disease.